Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes.

@article{Rasanen2013GlycosylatedFA,
  title={Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes.},
  author={Juha Rasanen and Caryn K. Snyder and Paturi Vishnupriya Rao and Raluca Cecilia Mihalache and Seppo Heinonen and Michael G. Gravett and Charles Roberts and Srinivasa R. Nagalla},
  journal={Obstetrics and gynecology},
  year={2013},
  volume={122 3},
  pages={586-94}
}
OBJECTIVE To evaluate the potential clinical utility of serum biomarkers for first-trimester prediction of gestational diabetes mellitus (GDM). METHODS Maternal serum concentrations of glycosylated (Sambucus nigra lectin-reactive) fibronectin, adiponectin, sex hormone-binding globulin, placental lactogen, and high-sensitivity C-reactive protein (CRP) were measured at 5-13 weeks of gestation in a case-control study of 90 pregnant women with subsequent development of GDM and in 92 control group… CONTINUE READING